Abstract: The cloning and heterologous expression of human T2 RNase6PL are disclosed. Further disclosed are methods for preventing, inhibiting and/or reversing cell motility, actin filament assembly or disassembly, proliferation, colonization, differentiation, accumulation and/or development of abnormal cells in a subject is disclosed. The methods are effected by administering to the subject a therapeutically effective amount of a RNase6PL ribonuclease or close homologues thereof.
Type:
Grant
Filed:
September 28, 2005
Date of Patent:
October 18, 2011
Assignee:
Yissum Reseach Development Company of the Hebrew University of Jerusalem
Abstract: The present invention provides a system for the determination of an analyte in a liquid medium. The system comprises a self-powered biosensor and a detector for measuring an electrical signal generated by said biosensor while the analyte is being oxidized or reduced, the biosensor comprising a pair of electrodes, one of the electrodes being an anode and the other a cathode, both of which carry redox enzymes on their surface. An enzyme carried on one of the electrodes can catalyze an oxidation or reduction reaction in which the analyte is oxidized or reduced, respectively, and the other of said pair of electrodes carries on its surface enzymes that can catalyze a reaction in which the oxidizer or the reducer are reduced or oxidized, respectively, in the presence of the analyte.
Type:
Grant
Filed:
August 12, 2002
Date of Patent:
February 3, 2009
Assignee:
Yissum Reseach Development Company of the Hebrew University of Jerusalem